Back to 
New York Life Investment Management LLC
New York Life Investment Management LLC
IBRX
Showing 0 of 5 quarters
Position history for New York Life Investment Management LLC's holdings in ImmunityBio, Inc.
No. New York Life Investments exited its IBRX (ImmunityBio) position in Q1 2024. Its Q4 2023 13F listed 191,221 shares worth $959,929. New York Life Investments first reported IBRX in Q1 2023 and held it in 4 quarterly 13F filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of IBRX: BlackRock, Inc., State Street Corp., Vanguard Portfolio Management LLC, Vanguard Capital Management LLC